Companies providing Inflammation & Skin Immunity
Inflammation & skin immunity assays and the pathways they cover
Skin reacts to irritants, UV and microbes through several linked systems. Keratinocytes sense microbial patterns through toll-like receptors (TLRs) and switch on the NF-κB pathway, which drives cytokines such as TNF-α, IL-1α, IL-6 and IL-8. Enzymes such as COX-2 then produce prostaglandins. Sensory nerves add a neurogenic layer through TRPV1 channels and substance P, and mast cells release histamine and other mediators. Each child service isolates one part of this network.
Neurogenic and sensitive-skin mechanisms
TRPV receptors modulation uses calcium imaging in TRPV1-expressing cells stimulated with capsaicin. Substance P regulation and neurogenic reduction measure neuropeptide release from sensory neuron models. These studies sit under sensitive skin and skin comfort efficacy testing.
Cytokines and signalling pathways
Cytokine profile modulation reads a panel of cytokines by ELISA or multiplex immunoassay. NF-κB pathway inhibition uses reporter or translocation assays. TNF-α/IL-6 suppression, cytokine cascade modulation, COX-2 inhibition, prostaglandin synthesis regulation and eicosanoid mediator control each target one step. Anti-inflammatory mediators increase testing measures signals such as IL-10, and inflammaging studies follow low-grade cytokine output in aged or repeatedly stressed cells.
Innate immunity and defence
Skin immunity efficacy testing groups TLR modulation, innate response activation, dendritic cell function, AMP production and β-defensin expression. Mast cell stabilisation studies measure degranulation markers such as histamine or β-hexosaminidase release.
Normalised marker data with viability and reference controls
Every study reports the model, trigger, concentrations, viability controls, a reference anti-inflammatory and the normalised marker data with statistics.
Services in Inflammation & Skin Immunity
Selecting inflammation & skin immunity studies for a soothing active
Most programmes combine a broad screen with one or two targeted pathway assays.
Match the pathway to the product’s positioning
For an after-sun or post-shaving active, UV- or irritant-triggered IL-1α, IL-8 and prostaglandin E2 are the usual readouts. Products for reactive skin with stinging or tingling suit TRPV1 and substance P work. An ingredient positioned on skin defence or microbiome balance fits AMP and β-defensin studies, where the goal is to support a response. Anti-ageing ranges built on calming chronic low-grade stress belong with inflammaging and cytokine profile studies.
Running a screening programme
Many suppliers start with a wide cytokine panel on several candidates, then take the best performer into a pathway assay such as NF-κB or COX-2 to explain the result. Ask for a dose range with a cytotoxicity test at each concentration, so a drop in cytokines can be read as activity in a healthy cell. A reference compound in the same run gives buyers a benchmark.
From cell data to consumer claims
Mechanism results support ingredient positioning and the technical data sheet. Finished-product claims on visible redness, stinging or comfort come from skin soothing & comfort efficacy testing on volunteers, and many dossiers present the two side by side.
More in Skin Comfort Testing
Skin soothing, comfort and redness efficacy testing measures visible redness and felt discomfort on volunteers, and inflammatory markers in skin models.

